Amgen Inc. (AMG)
FSX
Closed
Aug 21, 2026
Day's Range
367.0552 wk Range
230.00Overview - AMG - Amgen Inc.
Key Statistics
Valuation
Enterprise Value
211.12B
P/E (Trailing)
‪27.31‬
PEG Ratio
‪0.41‬
Price / Sales (TTM)
‪5.34‬
Price / Book
‪20.18‬
EV / EBITDA
‪14.31‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪22.95%‬
Operating Margin
‪35.54%‬
Return on Assets
‪8.66%‬
Return on Equity
‪91.47%‬
Ownership
Shares Outstanding
541.00M
Float
539.16M
Held by Insiders
‪0.22%‬
Held by Institutions
‪85.11%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪326.81‬
200-Day Avg
‪302.87‬
Dividends
Payout Ratio
‪60.87%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AMG - Amgen Inc.
Peers - AMG - Amgen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
Profile Summary - AMG - Amgen Inc.
About
Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on innovative medicines addressing serious illnesses in areas such as oncology, inflammation, cardiovascular disease, bone health, nephrology, and neurology. Key products target…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
